Cargando…

A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR

BACKGROUND: Currently, assessment of sentinel lymph node (SLN) requires cytology, hematoxylin-eosin (HE), and immunohistochemistry (IHC). However, routine pathological slides still suffer from certain sampling errors and have time limitations. This study sought to investigate the sensitivity and spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Jiuyan, Zhao, Meng, Deng, Huiyan, Liu, Chang, Cai, Lijing, Liu, Yueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638790/
https://www.ncbi.nlm.nih.gov/pubmed/36353583
http://dx.doi.org/10.21037/gs-22-485
_version_ 1784825502612062208
author Shang, Jiuyan
Zhao, Meng
Deng, Huiyan
Liu, Chang
Cai, Lijing
Liu, Yueping
author_facet Shang, Jiuyan
Zhao, Meng
Deng, Huiyan
Liu, Chang
Cai, Lijing
Liu, Yueping
author_sort Shang, Jiuyan
collection PubMed
description BACKGROUND: Currently, assessment of sentinel lymph node (SLN) requires cytology, hematoxylin-eosin (HE), and immunohistochemistry (IHC). However, routine pathological slides still suffer from certain sampling errors and have time limitations. This study sought to investigate the sensitivity and specificity of SLN detection by reverse transcription-polymerase chain reaction (RT-PCR), which quantifies the expression of mammaglobin and cytokeratin-19 genes to determine SLN status. METHODS: The RT-PCR detection of cycles threshold (CT) values has a direct relationship with the lymph node metastasis. This study prospectively collected 256 sentinel lymph nodes from 150 patients diagnosed with breast cancer between August and November 2017. In the detection of metastases in lymph nodes, molecular markers can be verified at the cell-level and tissue-level of tumor cells. In this study, IHC results were used as the gold standard for judging sentinel lymph node status. RESULTS: (I) According to the established cell models, as the lymph nodes in tumor cells increase, RT-PCR CT values decrease. (II) 83 lymph nodes were first collected, and the interpretation criteria for the molecular detection results were determined based on the IHC results. (III) The statistical analysis showed that the sensitivity of the RT-PCR was 80.49% and the specificity was 91.55%. The positive predictive and negative predictive values were 64.71% and 96.06%, respectively. There was no significant difference between RT-PCR detection and IHC detection (P=0.076). Statistical chi-square analysis also showed that the difference between intraoperative freezing and immunohistochemistry was statistically significant (P=0.000). There was a statistically significant difference between intraoperative freezing and RT-PCR detection (P=0.000). RT-PCR detection is more sensitive than intraoperative frozen detection, and is closer to the results of immunohistochemistry. CONCLUSIONS: RT-PCR had objective and rapid output advantages, and was proven to be true and reliable. RT-PCR detection can not only rapidly assess sentinel lymph node status in breast cancer patients during surgery, but its accuracy is also close to that of IHC. Correctly determine whether to perform axillary lymph node dissection and improve the survival rate of patients.
format Online
Article
Text
id pubmed-9638790
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-96387902022-11-08 A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR Shang, Jiuyan Zhao, Meng Deng, Huiyan Liu, Chang Cai, Lijing Liu, Yueping Gland Surg Original Article BACKGROUND: Currently, assessment of sentinel lymph node (SLN) requires cytology, hematoxylin-eosin (HE), and immunohistochemistry (IHC). However, routine pathological slides still suffer from certain sampling errors and have time limitations. This study sought to investigate the sensitivity and specificity of SLN detection by reverse transcription-polymerase chain reaction (RT-PCR), which quantifies the expression of mammaglobin and cytokeratin-19 genes to determine SLN status. METHODS: The RT-PCR detection of cycles threshold (CT) values has a direct relationship with the lymph node metastasis. This study prospectively collected 256 sentinel lymph nodes from 150 patients diagnosed with breast cancer between August and November 2017. In the detection of metastases in lymph nodes, molecular markers can be verified at the cell-level and tissue-level of tumor cells. In this study, IHC results were used as the gold standard for judging sentinel lymph node status. RESULTS: (I) According to the established cell models, as the lymph nodes in tumor cells increase, RT-PCR CT values decrease. (II) 83 lymph nodes were first collected, and the interpretation criteria for the molecular detection results were determined based on the IHC results. (III) The statistical analysis showed that the sensitivity of the RT-PCR was 80.49% and the specificity was 91.55%. The positive predictive and negative predictive values were 64.71% and 96.06%, respectively. There was no significant difference between RT-PCR detection and IHC detection (P=0.076). Statistical chi-square analysis also showed that the difference between intraoperative freezing and immunohistochemistry was statistically significant (P=0.000). There was a statistically significant difference between intraoperative freezing and RT-PCR detection (P=0.000). RT-PCR detection is more sensitive than intraoperative frozen detection, and is closer to the results of immunohistochemistry. CONCLUSIONS: RT-PCR had objective and rapid output advantages, and was proven to be true and reliable. RT-PCR detection can not only rapidly assess sentinel lymph node status in breast cancer patients during surgery, but its accuracy is also close to that of IHC. Correctly determine whether to perform axillary lymph node dissection and improve the survival rate of patients. AME Publishing Company 2022-10 /pmc/articles/PMC9638790/ /pubmed/36353583 http://dx.doi.org/10.21037/gs-22-485 Text en 2022 Gland Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Shang, Jiuyan
Zhao, Meng
Deng, Huiyan
Liu, Chang
Cai, Lijing
Liu, Yueping
A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR
title A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR
title_full A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR
title_fullStr A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR
title_full_unstemmed A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR
title_short A clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step RT-PCR
title_sort clinical diagnostic test on the detection of sentinel lymph node metastasis in breast neoplasms using a 1-step rt-pcr
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638790/
https://www.ncbi.nlm.nih.gov/pubmed/36353583
http://dx.doi.org/10.21037/gs-22-485
work_keys_str_mv AT shangjiuyan aclinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT zhaomeng aclinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT denghuiyan aclinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT liuchang aclinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT cailijing aclinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT liuyueping aclinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT shangjiuyan clinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT zhaomeng clinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT denghuiyan clinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT liuchang clinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT cailijing clinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr
AT liuyueping clinicaldiagnostictestonthedetectionofsentinellymphnodemetastasisinbreastneoplasmsusinga1steprtpcr